Biotransformation of myrislignan by rat liver microsomes in vitro

Phytochemistry

Volumn 69, Issue 3, 2008, Pages 765-771

  Li, Fei ^a   Yang, Xiu Wei ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

Biotransformation; Erythro (1R, 2S) 2 (4 allyl 2,6 dimethoxyphenoxyl) 1 (4 hydroxyl 3 methoxyphenyl) propan 1 ol; Myrislignan; Myrislignanometins A G; Myristica fragrans; Myristiceae; Neolignan

Indexed keywords

LIGNAN;

ANIMAL; ARTICLE; BIOTRANSFORMATION; CHEMISTRY; CONFORMATION; ISOLATION AND PURIFICATION; LIVER MICROSOME; MALE; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUTMEG; PLANT SEED; RAT; SPRAGUE DAWLEY RAT; STEREOISOMERISM;

ANIMALS; BIOTRANSFORMATION; LIGNANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICROSOMES, LIVER; MOLECULAR CONFORMATION; MYRISTICA FRAGRANS; RATS; RATS, SPRAGUE-DAWLEY; SEEDS; STEREOISOMERISM;

MYRISTICA FRAGRANS; RATTUS;

EID: 38349140478     PISSN: 00319422     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phytochem.2007.09.008     Document Type: Article

References (36)

1. Besombes S., Robert D., Utille J.P., Taravel F.R., and Mazeau K. Molecular modeling of syringyl and p-hydroxyphenyl β-O-4 dimers. Comparative study of the computed and experimental conformational properties of lignin β-O-4 model compounds. J. Agric. Food. Chem. 51 (2003) 34-42
2. Beyer J., Ehlers D., and Maurer H.H. Abuse of nutmeg (Myristica fragrans Houtt): studies on the metabolism and the toxicologic detection of its ingredients elemicin, myristicin, and safrole in rat and human urine using gas chromatography/mass spectrometry. Ther. Drug Monit. 28 (2006) 568-575
3. Boberg E.W., Miller E.C., Miller J.A., Poland A., and Liem A. Strong evidence from studies with brachymorphic mice and pentachlorophenol that 1′-sulfooxysafrole is the major ultimate electrophilic and carcinogenic metabolite of 1′-hydroxysafrole in mouse liver. Cancer Res. 57 (1983) 115-121
4. Bohlin C., Persson P., Gorton L., Lundquist K., and Joensson L.J. Product profiles in enzymic and non-enzymic oxidations of the lignin model compound erythro-1-(3,4-dimethoxyphenyl)-2-(2-methoxyphenoxy)-1,3-propanediol. J. Mol. Catal. B: Enzym. 35 (2005) 100-107
5. Chan V.S., and Caldwell J. Comparative induction of unscheduled DNA synthesis in cultured rat hepatocytes by allylbenzenes and their 1′-hydroxy metabolites. Food Chem. Toxicol. 30 (1992) 831-836
6. Crestini C., Pastorini A., and Tagliatesta P. The immobilized porphyrin-mediator system Mn(TMePyP)/clay/HBT (clay-PMS): a lignin peroxidase biomimetic catalyst in the oxidation of lignin and lignin model compounds. Eur. J. Inorg. Chem (2004) 4477-4483
7. Curti C., Zanardi F., Battistini L., Sartori A., Rassu G., Pinna L., and Casiraghi G. Streamlined, asymmetric synthesis of 8,4′-oxyneolignans. J. Org. Chem. 71 (2006) 8552-8556
8. De Vincenzi M., Silano M., Maialetti F., and Scazzocchio B. Constituents of aromatic plants: II. Estragole. Fitoterapia 71 (2000) 725-729
9. Evans P.A., and Leahy D.K. Regioselective and enantiospecific rhodium-catalyzed allylic alkylation reactions using copper (I) enolates: synthesis of (-)-sugiresinol dimethyl ether. J. Am. Chem. Soc. 125 (2003) 8974-8975
10. Forrester M.B. Nutmeg intoxication in Texas, 1998-2004. Hum. Exp. Toxicol. 24 (2005) 563-566
11. Gardner I., Bergin P., Stening P., Kenna J.G., and Caldwell J. Immunochemical detection of covalently modified protein adducts in livers of rats treated with methyleugenol. Chem. Res. Toxicol. 9 (1996) 713-721
12. George S., Narina S.V., and Sudalai A. A short enantioselective synthesis of (l)-chloramphenicol and (d)-thiamphenicol using tethered aminohydroxylation. Tetrahedron 62 (2006) 10202-10207
13. Green R.C. Nutmeg poisoning. J. Am. Med. Assoc. 171 (1959) 166-168
14. Hada S., Hattori M., Tezuka Y., Kakiuchi N., and Namba T. New neolignans and lignans from the aril of Myristica fragrans. Phytochemistry 27 (1988) 563-568
15. Hallstrom H., and Thuvander A. Toxicological evaluation of myristicin. Nat. Toxins 5 (1997) 186-192
16. Hasheminejad G., and Caldwell J. Genotoxicity of the alkenylbenzenes alpha- and beta-asarone, myristicin and elimicin as determined by the UDS assay in cultured rat hepatocytes. Food Chem. Toxicol. 32 (1994) 223-231
17. Hattori M., Hada S., Shu Y.Z., Kakiuchi N., and Namba T. New acyclic bis-phenylpropanoid from the aril of Myristica fragrans. Chem. Pharm. Bull. 35 (1987) 668-674
18. Hattori M., Hada S., Watahiki A., Ihara H., Shu Y.Z., Kakiuchi N., Mizuno T., and Namba T. Studies on dental caries prevention by traditional medicines X. Antibacterial action of phenolic components from mace against Streptococcus mutans. Chem. Pharm. Bull. 34 (1986) 3885-3893
19. Hattori M., Yang X.W., Shu Y.Z., Kakiuchi N., Tezuka Y., Kikuchi T., and Namba T. New constituents of the aril of Myristica fragrans. Chem. Pharm. Bull. 36 (1988) 648-653
20. Isogai A., Murakoshi S., Suzuki A., and Tamura S. Isolation from nutmeg of growth inhibitory substances to silkworm larvae. Agric. Biol. Chem. 37 (1973) 889-895
21. Kasahara H., Miyazawa M., and Kameoka H. Absolute configuration of 8-O-4′-neolignans from Myristica fragrans. Phytochemistry 40 (1995) 1515-1517
22. Kasahara H., Miyazawa M., and Kameoka H. Biotransformation of an acyclic neolignan in rats. Phytochemistry 38 (1995) 343-346
23. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
24. Matsumoto, A., Matsumoto, T., Tokuda, H., 1991. Lignans from mace as neoplasm inhibitors. Jpn. Kokai Tokkyo Koho, pp. 4.
25. Miyazawa M., Kasahara H., and Kameoka H. Antifungal activities of 8-O-4′-neolignans from Myristica fragrans. Nat. Prod. Lett. 8 (1996) 271-273
26. Nakajima, K., Yamazaki, T., Kawashima, K., Shinho, Y., Kurashige, T., Nohara, T., Kinjo, Y., Imakiire, M., Nishimura, M., 1999. Vascular smooth muscle contraction inhibitors from Myristica. Jpn. Kokai Tokkyo Koho, pp. 8.
27. Omura T., and Sato R. The carbon monoxide-binding pigment of liver microsomes II. Solubilization, purification, and properties. J. Biol. Chem. 239 (1964) 2379-2385
28. Payne R.B. Nutmeg intoxication. N. Engl. J. Med. 269 (1963) 36-38
29. Shin K.H., and Woo W.S. Inhibition and induction of hepatic mixed function oxidase by phenylpropanoids from the seeds of Myristica fragrans. Han'guk Saenghwa Hakhoechi 23 (1990) 122-127
30. Stein U., Greyer H., and Hentschel H. Nutmeg (myristicin) poisoning - report on a fatal case and a series of cases recorded by a poison information center. Forensic Sci. Int. 118 (2001) 87-90
31. Wang Y., Yang X.W., Tao H.Y., and Liu H.X. GC-MS analysis of essential oil from seeds of Myristica fragrans in Chinese market. China J. Chin. Mater. Med. 29 (2004) 339-342
32. Yang X.W. Absorption, Distribution, Metabolism, Excretion, Toxicity and Activity of the Chemical Constituents in Traditional Chinese Medicines (2006), China Medical-Pharmaceutical Science & Technology Publishing House, Beijing pp. 301-387
33. Yang X.W., Aihemaiti M.M.T., Li Q., Xu W., Yang Z., and Xiao S.Y. Studies on chemical constituents from seeds of Myristica fragrans. Chin. Tradit. Herb. Drugs 34 Suppl. (2003) 93-96
34. Yang X.W., Hao M.R., and Hattori M. Metabolite Analysis for Chemical Constituents of Traditional Chinese Medicines (2003), China Medical-Pharmaceutical Science & Technology Publishing House, Beijing pp. 265-699
35. Yao Q.Q., and Wang M.Z. Studies on metabolism of (-)-clausenamide by rat liver microsomes. Acta Pharm.Sinica. 33 (1998) 296-299
36. Zhong D.F. Drugs Metabolism (1996), China Medical-Pharmaceutical Science & Technology Publishing House, Beijing pp. 3-6